Docusign stock price target raised to $102 from $85 at BofA Securities

DocuSign (NASDAQ:DOCU) has received multiple analyst price target increases, most notably BofA Securities raising its target to $102 from $85 while maintaining a Neutral rating, following a robust second quarter that exceeded revenue, EPS, and billings forecasts. This positive sentiment stems from improved execution in its core eSignature business and momentum in its strategic Identity and Access Management (IAM) segment, which analysts view as a significant long-term opportunity. However, BofA's continued Neutral rating suggests much of the near-term upside is already priced into the shares, despite the company's strong gross margins and improving net revenue retention.

Analysis

DocuSign (DOCU) is demonstrating significant operational improvement, as evidenced by its robust second-quarter results which surpassed analyst expectations. The company reported revenue of $801 million against a forecast of $780.1 million, and earnings per share of $0.92, beating the expected $0.85. Critically, billings were a standout at $818 million, well ahead of the projected $762.5 million, signaling strong future revenue. This performance is further supported by an improving net revenue retention rate, which increased to 102% from 101% in the prior quarter. Consequently, several research firms have raised their price targets, including BofA Securities to $102, RBC Capital to $95, and Evercore ISI to $92. BofA's upgrade is based on a higher valuation multiple (20x calendar year 2026 estimated free cash flow, up from 17x), justified by better execution in the core eSignature business and momentum in the emerging Identity and Access Management (IAM) segment. However, despite the bullish price targets, BofA, RBC, and Evercore all maintain neutral-equivalent ratings, suggesting a consensus view that the stock's current valuation, at 15.8x CY26E FCF, already incorporates much of this near-term positive news. The IAM opportunity, while a key long-term catalyst, is still described as being in an early cycle with go-to-market efforts still a work in progress.

Key Decisions for Investors

• Acknowledge the strong operational momentum demonstrated by DocuSign's Q2 revenue, EPS, and billings beat, which underpins the recent positive analyst sentiment.
• Carefully weigh the company's impressive fundamentals, including a 79.47% gross margin and improving retention, against its current valuation, as analysts' neutral ratings suggest that much of the near-term upside may already be priced into the shares.
• Monitor the execution and adoption of the emerging Identity and Access Management (IAM) business, as its successful development is a key long-term catalyst for strategic growth but currently remains in an early stage with associated go-to-market risks.